And Thanks, Steve. morning, everyone. good
momentous the our of our year both of Healthcare, merger, we Walgreens execution the and positioning. For the AmerisourceBergen, Brunswig another a extension fiscal XXXX, Bergen of celebrated continued performance as and XXXX was contract of strategic Alliance XXth the by Amerisource and completed year anniversary acquisition and driven delivered team the strong through
scale. centric robust pharmaceutical relationships, distribution leadership us access a business, customer Our and specialty services, partner innovation on in in be conditioned pharmaceutical - to a global supporting and and
to a against results my financial stated. are prior unless otherwise September adjusted non-GAAP reminder, will rates remarks made the Before results, focus as turn on comparisons I our year, and Growth Quarter. today our
in our release. main please refer results, commentary For I this areas detailed morning. a provide GAAP of X discussion to will our earnings
we review results XXXX XXXX performance our segments beginning fourth-quarter and will segment with guidance. reporting then fiscal Beginning it consolidated fiscal will discuss conclude First, in the of fiscal in was worth the I from will our XX.X%, segment. and our and in of Distribution Healthcare performance new our with XXXX, and results, with which EPS strong full of increase an by a Pharmaceutical contribution adjusted driven both quarters finished Services $X.XX, quarter Alliance diluted
other. approximately distribution was revenue reflecting in and consolidated million XX% pharmaceutical Our up $XX.X growth
the Excluding pharmaceutical Alliance which Healthcare, $X Consolidated inclusion up revenue been from Alliance billion gross other profit benefited consolidated gross in would profit of by up driven both in from have and the XX% Healthcare. X% quarter. increases distribution prior-year our was
quarter's gross support period, in the million future basis full as prior-year due addition $X.X to quarter $XXX of primarily and margin the as were current investments growth. the This we points than and prior-year Alliance had consolidated to results. in initiatives Healthcare quarter X.X% of XX operating is talent, higher expenses a well Company's versus our billion profit in Healthcare, of Alliance the our Consolidated as
our is than operating in of comparison quarter's reversal fourth we of primarily impact higher in year expenses. quarter, XX debt expense results. as X.XX% Also, consolidated million the This full had reminder, that of the year-over-year the XXXX, margin points operating a quarter bad fiscal prior impacts a $XX Healthcare basis quarter reflecting Alliance the
Turning consolidated now to income. operating
the from driven which I in Our was income growth compared prior income I Services from was increases in $XXX benefit Pharmaceutical margin an basis continued and segment to up Healthcare X.XX%, Distribution detail review operating million, a This by of XX% and segment discuss result was when our more the performance. XX year Operating some as other, both quarter. increase level higher-margin points Alliance of the will of businesses. the contribution
Healthcare. debt our the expense to Alliance was interest rate and million, expense $XX interest to related tax now XX% for Net Moving Quarter. effective due to net up Fourth
quarter. due Our quarter. the effective prior-year income a tax rate from domestic prior-year tax compared and to XX.X% international effective rate in XX.X% was in was to change mix of the lower income The
count as compensation. X the increase delivered related to diluted of million X.X% and the shares of acquisition part XXX.X results. was Healthcare Our Alliance due to of This impact the dilution the consolidated at review Walgreens issuance our share employee to million stock of completes shares
in inclusion during from to by from growth includes benefits Pharmaceutical concludes will continued commercialization XXXX and allowed Distribution as us Alliance revenue well the margin strong across utilization from animal quarter, specialty basis $X.X That million businesses. utilization I'll our full other, by to I turn quarter. revenue as quarter by Alliance $XX.X Now, the $XXX Courier, AmerisourceBergen's quarter Businesses, now the income in Distribution products, $X operating World X.XX% Pharmaceutical AmerisourceBergen $XXX Services an to trends. the of turn capture million. positive the Healthcare, by up income which the Healthcare, services specialty fourth segment quarter. for points of increased Alliance segment strong and XXXX, our to trends the million the fiscal quarter. XX% Services Driven $XXX results X% overall quarter. up to up execution the X in distribution billion, Operating operating sales of expanded billion quarter was segment in income Pharmaceutical of Distribution prescription contribution increased was fiscal discussion. to fourth was fourth worth fourth of MWI, and Other Healthcare. fiscal the a in other In due health driven our quarter's consulting. of in global billion leadership
discussion a results. Now XXXX fiscal will our of turn I to full-year
million Healthcare. Alliance $XXX by driven X revenue up includes Distribution Our XX% of growth in months other, consolidated was and which from contribution Pharmaceutical
operating the the Alliance Excluding of driven income from Alliance contribution for grew X-month $X.X prior Consolidated performance our and X% by across billion, was revenue businesses year. strong our up Healthcare, to the consolidated year Healthcare. XX%
to systems. our solutions the leadership of Alliance to Excluding year and systems from and portfolio consolidated fundamentals team segment hospitals higher-margin as our performance by distribution, both less space and across work capitalize Healthcare, meet of logistics for health increased driven our by leveraged to due COVID-XX for We we contribution has to support distribution perspective, hospitalized XX% income the distribution important health operating and that country. And XX% from growth therapies in addition differentiated business, to and on significant was patients. businesses customers. a the saw pharmaceutical continued antivirals of XXXX had fiscal a complex by specialty strong our COVID manufacturers the across income the an exceptional our therapy done in prior growth our services From our strong distribution businesses, across operating
strong to services physician fiscal this and Additionally, we continue specialty performance have year.
four the in more and normal new current more As screening processes testing has of physician accustomed and starts. This levels diagnosis the environment. in patient related operating strong system supported resulting to healthcare meaningfully become the grew of from and $XXX million. income also contribution to from delivers Other XX% while results In results. other, World Courier benefited Alliance Healthcare months year-over-year MWI operating
As Courier alternative and challenged as manufacture to companion experience reopening World global their care in provided by their demand. market, of as and strong health. boosted pandemic, continued market its Production differentiator the is be protein shipments. pet clinical maintain continued parents the solutions World other the Courier sensitive animal sites. acuity temperature to be partners around focus patient on the the MWI logistics a trials to of saw movement continued pet's and manufacturers travel facilitating restaurants performance the world, innovative priority high to direct and expertise lower Animal patients In return of to in-home
Turning now tax rate prior adjusted was from XXXX effective fiscal discrete to tax fiscal rates, the our benefited compared year, for to which XX.X% tax items. XX.X% in
cash was Turning growth due full-year primarily and flow across and in EPS, better strong primarily due supplier $X.X our grew our contribution than XX% EPS billion, flow the in expectations due for month the now December at and expected also continued to timing will business, Alliance to to Alliance the Adjusted from There benefit to $X.XX our cash was free payables. diluted quarter leadership of out-performance four Healthcare. which September, reverse certain including the adjusted year And higher better was specialty. and than payments a customer that Healthcare. execution
reporting, I approximately results. of go our benefit, cash review fiscal That $X.X ban, the our normalize into in you of of million. adjusted billion, our $X.X to the completes was XXXX. a discuss which excluding for of $XXX ended now XXXX the balance year cash flow cash year will with effect a roughly the segment updates fiscal will If restricted We timing-related million. free
to we the undertook business how strategic change in and acquisition of subsequent Following of operations. we business, Alliance to our our geography the alignment provide a report segments with order the in evaluation Healthcare
pharmaceutical or October, excluding concluded will which Pharmaceutical in review, fiscal our first legacy Profarma healthcare and and Distribution, which and X World distribution our this segments the and international businesses new of and results solutions. Distribution reporting in begin non-US XPL. reported of Profarma segment services ICS The quarter including healthcare and Solutions solutions will Courier Services XXXX. Profarma in based plus Healthcare group U.S. distribution Specialty. previously Xcenda been segment, U.S. our of Following we Segment solutions had The Animal healthcare Amar Health, Healthcare consist other. solutions, marsh Alliance following MWI International and consist
the our in morning, we was X-K results reminder, for financial with reported consolidate also a of your are order quarterly As we Specialty previously entity. for re-segmented due and interest farmers XXXX Profarma fiscal modeling. Form publicly This ownership filing to to and traded help governance other.
the foundation pharmaceutical segments, by markets. reporting key like and higher-margin offering in value-added distribution of and new on Our complementary AmerisourceBergen differentiated businesses are leading solutions built
Turning XXXX as forward-looking guidance reminder, discuss do on fiscal our a And we to GAAP guidance. not basis. provide now a
be we Solutions, basis. range. level, of revenue single-digit on healthcare percent $XXX all provided representing Starting an Healthcare international adjusted of metrics So the In we to $XX a X% revenue, $XXX we double-digit $XX billion expect non-GAAP revenue expect approximately billion. with consolidated U.S. to X% billion of grow solutions to to are highest On the approximately growth in to year-over-year. following billion to expect low segment revenue
Moving was consolidated in Solutions is fiscal segment that contributed X% operating and income revenues included not on has Proforma going percent between $X.XXX high basis. XXXX, services we X% in year-over-year growth to income. On segment than representing X% less Solutions that U.S. grow range to to business of the and a Distribution, on to $X.X services The pharmaceutical of X% level, pharmaceutical distribution distribution operating operating Healthcare billion billion operating the U.S. expect only of for Healthcare we which income, a income be into roughly and to teens expect mid
in XXXX We in therapies. as benefit primarily have As The in we for sales month of substantial from fiscal sales in tailwind in COVID EPS to in said September. August therapy final quarter, therapy declines which sales first COVID the subsequent was the the than of by in driven again full-year fourth did contribution February the related with $X.XX, from was quarter. sales $X.XX financial August, expected significant a of a had reminder, the I fiscal XXXX higher and back COVID-XX
COVID on sales for the fiscal If based October $X.XX contribution have an lower you therapies would which $X.XX, Quarter Solutions first means the even from that Healthcare Segment. be of First trends, U.S. the XXXX would quarter estimate headwind
this reduces X% to growth rate the expect growth we full-year While first in in healthcare U.S. income quarter, of operating X% segment's fiscal the solutions.
million solutions to Alliance healthcare segment international little income a $XXX the Courier in of of expect Healthcare with have dollars. $XXX two-thirds operating over between and of represents up operating We income. the million the operating majority making segment income World remainder
XX% models, As you your about think we segment's of the quarter. international first income operating expect first-quarter about to occur the in
fiscal you mind. couple look a As international segments, in at of XXXX are to for things there keep the
First, completed represents Specialty as under the transaction review our to a to of we our half our regulatory expected core first Successful we X% and the completion and have agreed be Profarma is sell factored of is XXXX. divestiture The operating focus into fiscal on income. assets. operating in Solutions Healthcare headwind to guidance segment's is international
when Healthcare Alliance have in was related at fully and expenses XXXX, in contemplated to generally step-up the announced a modernization. will we Second that we is I.T. fiscal acquisition
Steve focused this As relationships. continue in long-term stakeholders through fiscal infrastructure Alliance expectations said Alliance fiscal deep across EPS for efficient expense both our as and align Healthcare's diluted earlier, held innovative businesses. business have and our be for leaders and our manufacturer collective AmerisourceBergen, solutions. And alliance continuity. a systems the business the our around view Healthcare technology to XXXX thoughtfulness to closing we our on and technology, standalone impressed recently, as to teams virtually services, high Alliance to with dive step-up Most have fundamental by adjusted continues creating on be Alliance business, Healthcare and engaged accretive pains, the AmerisourceBergen we XXXX. Since with in been and and to operability, and and strong I value will furthered and our in-person business Alliance help Transaction, strong operations we Healthcare deliver appreciate team the expect
as of Moving rate count, percent to related grow debt we onto Alliance share Healthcare result mid-teens a interest in range expense the tax expense, expect acquisition. the and to interest
benefit tax range based have tax the We our are top fiscal on range. XX% But both to tax on for and operations would bottom expect of rate end approximately rates for effect rate higher XXXX to current XXXX. the be Alliance Healthcare's fiscal in the now X% been XX% from
shares Finally, we acquisition approximately million XXX closing as share as delivered to shares the our of expect impact that the will the million and part a full-year expense. Healthcare of compensation from of dilution the count of normal to Walgreens Alliance increase result X stock
XXXX. As we a years paying our in billion half credit our towards part to rating, to end down grade next lieu share over it's the maintain debt commitment down total of fiscal in committed to reminder, amount of are $X the roughly expect repurchases. X currently pay strong of investment We that
$XX.XX. Reflecting growth to As be are a of of to reflecting to year-over-year these diluted EPS in result of XX% the range of expectations, strength the $XX.XX XX%. our business, we guiding for adjusted
and business opportunities. to Alliance CapEx Turning to infrastructure and our expectations, now advance the million as support expenditures range or be additional buy we flow expected to further capital to continue in $XXX invest is growth to of Healthcare's IT cash
adjusted expect which strong persisted. another pandemic our strategic team results. AmerisourceBergen partners, as and execute flow proud to cash in billion, and the customers, Alliance drove for financial $X.X Healthcare our priorities, cash our be who free our support to fiscal continue work of range For fiscal entire successful while of members $X the tirelessly year the was we the adjusted to in billion patients, on I'm of benefit results year. flow, for we XXXX XX,XXX to In free closing, includes our
value. our about our stakeholder XXXX I'm the to deliver fiscal business, to XXXX steps excited we took in year continue Given advance we as
call pharmaceutical we higher partners is on and built responsibility line is of our unparalleled turn With manufacturer our dedicated a expertise differentiated distribution operator pharmaceutical provider futures and united I we As our value and leadership capabilities, and Operator. our questions. team open the healthcare differentiated foundation continue our AmerisourceBergen create maintain to by to drive complementary over healthier by customers. to guided on by create for members. that the to forward, in will the our focus of that supported business our purpose to leverage our margin businesses scale will being
